Industry Resources2019-11-21T14:51:21+00:00

Industry Resources

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

Finding Value in Digital Therapeutics During COVID-19

As COVID-19 continues to impact how populations with chronic diseases and mental health conditions across the world are living and receiving healthcare, it is important to consider how the use of a new category of [...]

DTA Announces 2020 Board of Directors

The Digital Therapeutics Alliance (DTA) is pleased to welcome the following individuals to the DTA Board of Directors: Peter Hames, Co-Founder and CEO, Big Health Anand Iyer, Chief Strategy Officer, WellDoc Pierre Leurent, Founder and [...]

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

Express Scripts Announces Digital Health Formulary

Our industry-first Digital Health Formulary will allow employers and health plans to manage this fast-growing segment of health care while improving access for patients. As more people turn to digital programs to help manage serious [...]

What if we get things right? Visions for 2030

World Economic Forum (Ceri Parker) -- We asked members of our Global Future Councils - academics, business leaders and members of civil society - to imagine a better world in 2030. Only by thinking about where [...]

Load More Posts

DTx Member Companies in the News

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Ozone Exposure Associated with Asthma Symptoms

New data from digital inhalers confirms that exposure to the air pollutant ozone is strongly linked to increased use of inhaled medications for asthma symptoms, according to a new study from CommonSpirit Health; Propeller Health; [...]

Load More Posts

Stay Up To Date

SIGN UP FOR DTA NEWS & UPDATES

Sign Up Now